Mycamine and disease recurrence Patient Reports February 10, 2010
Mycamine Side Effects Report #6078421-3
Mycamine side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Male patient was diagnosed with systemic candida and was treated with Mycamine. After drug was administered, patient experienced the following side effects: alpha 1 foetoprotein abnormal, calcinosis, catheter related infection, disease recurrence, hepatoblastoma, klebsiella infection, liver abscess, pyelonephritis, renal disorder. Mycamine dosage: 4.95 MG/KG, UID/QD, 54 MG/KG, UID/QD. During the same period patient was treated with NEUPOGEN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Mycamine Side Effects Report #6093007-2
Mycamine side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Male patient was diagnosed with systemic candida and was treated with Mycamine. After drug was administered, patient experienced the following side effects: central line infection, disease recurrence, hepatoblastoma, oesophageal stenosis, pneumonia klebsiella, pyelonephritis, systemic candida, vomiting. Mycamine dosage: 4.95 MG/KG, UID/QD; 4 MG/KG, UID/QD. During the same period patient was treated with NEUPOGEN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Mycamine Side Effects Report #6101528-9
Mycamine side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Male patient was diagnosed with systemic candida and was treated with Mycamine. After drug was administered, patient experienced the following side effects: candidiasis, central line infection, disease recurrence, hepatoblastoma, kidney malrotation, oesophageal stenosis, pneumonia klebsiella, pyelonephritis, renal fusion anomaly. Mycamine dosage: 4.95 MG/KG, UID/QD; 4 MG/KG, UID/QD. During the same period patient was treated with NEUPOGEN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Mycamine Side Effects Report #6124364-6
Mycamine side effect was reported by a Physician from UNITED STATES on Mar 03, 2009. Male patient was diagnosed with systemic candida and was treated with Mycamine. After drug was administered, patient experienced the following side effects: candidiasis, central line infection, disease recurrence, hepatoblastoma, horner's syndrome, oesophageal stenosis, pyelonephritis, vomiting. Mycamine dosage: 4.95 MG/KG, UID/QD,; 4 MG/KG, UID/QD,. During the same period patient was treated with NEUPOGEN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Mycamine and disease recurrence 